Funding

[Funding alert] Berlin-based Inuru Secures €10M in Funding

Oct 20, 2023 | By Startup Rise EU

Inuru, based in Berlin, secured €9.5 million. Aper Ventures, Adamed Technology, ARIA, and an assortment of business angels are the fund's sources, together with Adamed Pharma, a Polish pharmaceutical company, Adamed Pharma, and a venture capital firm.
Marcin Ratajczak - Founder/CEO Inuru

Inuru, based in Berlin, secured €10 million. Aper Ventures, Adamed Technology, ARIA, and an assortment of business angels are the fund's sources, together with Adamed Pharma, a Polish pharmaceutical company, Adamed Pharma, and a venture capital firm.

Although OLED technology has an array of benefits, its broad usage has been constrained by its expensive manufacturing costs. With the current infusion of investor support, Inuru is going to be able to expand into new businesses that can profit from more visible and interactive labels and spread its technology to a larger audience.

RECOMMENDED FOR YOU

recomd
Funding
Funding Wrap of the Week | European Startups Funding Roundup | March 3 – March 8
Startup Rise EU
Mar 9, 2024
recomd
Funding
[Funding alert] London-based Monument Secures over $50M in Series B Round Funding
Startup Rise EU
Nov 10, 2023
recomd
Funding
[Funding alert] Berlin-based Smalt Secures €4.1 Million in Pre-Seed Funding
Startup Rise EU
Nov 3, 2023

Inuru CEO Marcin Ratajczak said, “Adamed’s investment validates the pressing need for improved medication delivery. Our OLED labels empower brands to enhance medication adherence and help patients regain control over their health,”

The need for smarter, interactive labeling solutions is being pushed by the problem of patients who run the danger of consuming expired prescriptions and not following prescribed suggestions.

Read also - Ukraine-based Product Development Company Trinetix Raises $10 million in Funding

The effects of non-adherence and inappropriate drug management are thought to be contributing to 325,000 annual mortality and $600 billion (€570 billion) in avoidable healthcare costs.

The primary goal of Inuru is to use its technology, which has been recognized for improving product visibility on retail shelves, to develop smart and interactive labeling systems. The management of prescription drugs and medication intake could be revolutionized by these labels.

CFO of Inuru, Robert Chudala said, “As we aim to capitalise on our OLED technology to disrupt the healthcare and FMCG industries, we rigorously evaluate multiple financial avenues, including the prospect of an IPO,”

Read also - UK Fashion Resale peer-to-peer Startup NOLD €1 Million in Seed Funding

About Inuru

Embeddable Lighting Films (ELFs) from Inuru are self-powered, intelligent devices that give manufacturers a simple way to add illumination to their goods. This development opens the door to a brighter, more connected future.

The startup has been in the vanguard of using OLEDs in everyday products, maximizing their possibilities for marketing, entertainment, and safety. It has become well-known for employing its printed OLED technology to illuminate the bottles of well-known brands like Coca-Cola and Cattier.

Recommended Stories for You

story
Funding

Quorum Cyber funding news – UK-based Quorum Cyber Secures Strategic Growth Investment

Startup Rise EU Jun 7, 2024

story
Funding

PolyModels Hub funding news – English Biotech Software Platform PolyModels Hub Secures £1.1 Million in Seed Funding

Startup Rise EU Jul 9, 2024

story
France

[Funding alert] French Solar Energy Distributor Technique Solaire Raises €200 million in Funding

Startup Rise EU Nov 10, 2023

story
Funding

[Funding alert] Milan-based Guidoio Secures €700k Pre-Seed Funding

Startup Rise EU Feb 15, 2024

story
Funding

Grasp funding news -Stockholm-based Grasp Secures €1.7 Million in Funding

Startup Rise EU May 14, 2024

story
Funding

[Funding alert] Switzerland-based Clinical-Stage Radiopharmaceutical Company ARTBIO Secures $90M in Series A Round Funding

Startup Rise EU Dec 11, 2023